Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative PET Chemotherapy in Gastric Cancer
NCT01830270Phase 2Terminated
- Sponsor
- CHU de Besançon
- Start
- May 2011
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel in gastric cancer (GC), gastroesophageal junction cancer, esophageal cancer, sponsored by CHU de Besançon. Started May 2011; status: terminated.
02
Drugs
paclitaxel
03
Conditions
gastric cancer (GC)gastroesophageal junction canceresophageal cancer
Beyond the preview
Go deeper on NCT01830270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01830270.